| 000 | 00853nam a2200289Ia 4500 | ||
|---|---|---|---|
| 001 | 001666 | ||
| 008 | 141222s9999 xx 000 0 und d | ||
| 020 | _a0-913595-37-3 | ||
| 040 | _aDB/INS | ||
| 041 | 0 | _aeng | |
| 084 | _aR | ||
| 084 | _bQV738 AA1 U8s 1990 | ||
| 110 | 2 | _a22-24 Mar. 1985 | |
| 111 | 2 | _aUnited States Pharmacopeial Convention, Inc | |
| 111 | 2 | _cWashington, Estados Unidos | |
| 111 | 2 | _d22-24 Mar. 1985 | |
| 245 | 1 | 4 | _aThe United States Pharmacopeia, the national formulary |
| 245 | 1 | 0 | _cUSP XXII, NFX VII |
| 250 | _a21th ed | ||
| 260 | _aRockville | ||
| 260 | _bThe United States Pharmacopeial Convention | ||
| 260 | _c1990 | ||
| 300 | _aliv, 2067 | ||
| 500 | _aIntitución patrocinadora: Prepared by the Committee of Revision and Published by the Board of Trustees | ||
| 650 | 1 | _aFarmacopeas | |
| 710 | 2 | _aNFX VII | |
| 999 |
_c11089 _d11089 |
||